文献速递脊柱关节炎

患者总体评估不可用时替代强直性脊柱炎疾病活动度评分的开发与验证

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究基于四个中轴型脊柱关节炎队列和两项随机对照试验的纵向数据,开发并验证了当患者总体评估(PGA)缺失时用于研究场景的替代ASDAS。以BASDAI总分替代PGA的替代ASDAS在真实性、区分度和可行性上表现最佳。

要点

  • BASDAI总分替代PGA的替代ASDAS与原ASDAS一致性高(ICC=0.98,kappa=0.90)。
  • 替代ASDAS在PASS区分上标准化均数差为1.37,原ASDAS为1.43。
  • 替代ASDAS与原ASDAS在主要改善/临床重要改善标准上kappa=0.93/0.88。

核心结论

  • 以BASDAI总分替代PGA的替代ASDAS是真实性、区分度和可行性最优的替代工具。

研究设计与样本

  • 研究合并四个中轴型脊柱关节炎队列和两项随机对照试验的纵向数据。
  • 观察值随机分为开发队列(N=1026)和验证队列(N=1059)。
  • 在开发队列中以BASDAI总分、单个或组合BASDAI问题及常数替代PGA,通过广义估计方程定义转换因子,得到七种替代公式。
  • 在验证队列中按OMERACT滤器从真实性、区分度和可行性三方面进行验证。

主要发现

  • 替代ASDAS(BASDAI总分替代PGA)与原ASDAS在连续评分上ICC=0.98,在疾病活动状态上加权kappa=0.90。
  • 替代ASDAS在PASS否/是间的标准化均数差=1.37,原ASDAS为1.43。
  • 替代ASDAS与原ASDAS在主要改善/临床重要改善标准上kappa=0.93/0.88。
  • BASDAI总分常可获取,且转换系数≈1,可行性好。

关键数值与推荐

  • 替代ASDAS使用BASDAI总分作为PGA替代,转换系数≈1。
  • 真实性:ICC=0.98,加权kappa=0.90。
  • 区分度:PASS否/是间标准化均数差=1.37(原ASDAS=1.43)。
  • 改善标准一致性:主要改善kappa=0.93,临床重要改善kappa=0.88。

临床怎么用

  • 在数据库缺少PGA的研究场景中,可用BASDAI总分替代PGA计算替代ASDAS。
  • 替代ASDAS与原ASDAS一致性高,可用于疾病活动度评估和改善标准判定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop an alternative Ankylosing Spondylitis Disease Activity Score (ASDAS) to be used in research settings in axial SpA (axSpA) when Patient Global Assessment (PGA) is unavailable in databases. METHODS: Longitudinal data from four axSpA cohorts and two randomized controlled trials were combined. Observations were randomly split in a development (N = 1026) and a validation cohort (N = 1059). Substitutes of PGA by BASDAI total score, single or combined individual BASDAI questions, and a constant value, were established in the development cohort. Conversion factors for each substitute were defined by Generalized Estimating Equations, obtaining seven 'alternative' formulae. Validation was performed in the validation cohort according to the OMERACT filter, taking into consideration: (i) truth (agreement with original-ASDAS in the continuous score, by intraclass correlation coefficient and in disease activity states, by weighted kappa); (ii) discrimination [standardized mean difference of ASDAS scores between high/low disease activity states defined by external anchors, e.g. Patient Acceptable Symptom State; agreement (kappa) in the percentage of patients reaching ASDAS improvement criteria according to alternative vs original formulae]; and (iii) feasibility. RESULTS: Comparing various options, alternative-ASDAS using BASDAI total as PGA replacement proved to be: truthful (intraclass correlation coefficient = 0.98, kappa = 0.90), discriminative [ASDAS scores between Patient Acceptable Symptom State no/yes: standardized mean difference = 1.37 (original-ASDAS standardized mean difference = 1.43); agreement with original-ASDAS in major improvement/clinically important improvement criteria: kappa = 0.93/0.88] and feasible (BASDAI total often available, as questions required for the ASDAS; conversion coefficient ≈ 1). CONCLUSION: Alternative-ASDAS using BASDAI total score as PGA replacement is the most truthful, discriminative and feasible instrument.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Ortolan A, Ramiro S, van Gaalen F, et al. Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable. Rheumatology (Oxford). 2021. PMID: 32572483. doi:10.1093/rheumatology/keaa241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。